AbstractWHAT IS KNOWN AND OBJECTIVES:Gastric cancer is the most common gastrointestinal malignant tumour in China, which rarely me...
Apatinib plus chemotherapy shows clinical activity in advancedNSCLC: a retrospective study.Jing Tang1#, Xu Yong Li2#, Jing Bo Lian...
AbstractBackground:Apatinib, a novel small molecule vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibi...
AbstractNo definitive treatment strategy has been established for patients with metastatic colorectal cancer (mCRC) who experience...
AbstractOBJECTIVES:Advanced gastric cancer poses a therapeutic challenge worldwide. In randomised clinical trials, anti-VEGF has b...
AbstractApatinib has been proven to be effective and safe among patients in the third-line treatment of advanced gastric cancer in...
AbstractAs treatment options for hepatocellular carcinoma (HCC) are currently limited, we evaluated the efficacy and safety of ora...
AUTHOR: Guanghui Ji1, Liu Hong2, Ping Yang3SOURCE: OncoTargets and TherapyAbstract:Angiosarcoma is a rare and aggressive vascular...
[Deutsche Bank Markets Research]Hengrui Medicine ReportClick for details